Tocqueville Asset Management’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,965
Closed -$1.45M 847
2017
Q3
$1.45M Sell
1,965
-720
-27% -$598K 0.02% 487
2017
Q2
$2.33M Sell
2,685
-100
-4% -$83.8K 0.03% 408
2017
Q1
$2.36M Hold
2,785
0.03% 399
2016
Q4
$2.12M Sell
2,785
-130
-4% -$98.2K 0.03% 405
2016
Q3
$2.4M Hold
2,915
0.03% 387
2016
Q2
$2.43M Buy
2,915
+1,120
+62% +$935K 0.03% 383
2016
Q1
$1.65M Buy
1,795
+670
+60% +$641K 0.02% 424
2015
Q4
$1.16M Buy
+1,125
New +$1.13M 0.02% 512

Other funds holding AGN.PRA

Tocqueville Asset Management's AGN.PRA Position: Q4 2017 in Review

Tocqueville Asset Management sold out of Allergan plc (AGN.PRA) in Q4 2017, closing a stake of 1,965 shares — an estimated $1.45M sold.

Tocqueville Asset Management first reported a position in AGN.PRA in Q4 2015 and held it in 8 quarters. The position peaked at $2.43M in Q2 2016. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • Tocqueville Asset Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Tocqueville Asset Management sold 1,965 Allergan plc shares in Q4 2017, an estimated $1.45M.
  • Tocqueville Asset Management first reported a position in Allergan plc in Q4 2015 and held it in 8 quarters.
  • Tocqueville Asset Management's Allergan plc position peaked at $2.43M in Q2 2016.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Tocqueville Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.